- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01869712
PRPP Model for Evaluation the Effect of Non-pharmaceutical Therapies
July 9, 2019 updated by: Huijuan Cao, Beijing University of Chinese Medicine
Using Partially Randomized Patient Preference Research Model for Evaluation the Therapeutic Effect of Non-pharmaceutical Therapies: Protocol for a Feasibility Study
To assess the application of partially randomized patient preference (PRPP) trial model which concerns the patients' preference on evaluation the therapeutic effect of non-pharmaceutical therapy, and to observe the therapeutic effect of two kinds of non-pharmaceutical therapies (acupuncture and cupping therapy) for fibromyalgia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100078
- Beijing University of Chinese Medicine Affiliated Dongfang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with fibromyalgia diagnosed according to criteria formulated by American College Rheumatology 2002;
- Patients whose scores for pain intensity is more than 30mm;
- Patients who are 20 to 60 years old;
- Patients who fully understand the process of this research and who are willing to provide informed consent.
Exclusion Criteria:
- The widespread muscular-skeletal pain is caused by some kind of disease, surgery, or other external interference factors (except fibromyalgia);
- Patients with mental disorders, or other serious organic diseases, such as organ failure;
- Patients who take oral anodyne medications or accept other interventions for pain relief during the treatment;
- Pregnant or lactating women;
- Patients currently participating in another clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cupping therapy (randomized)
Use retained cupping as the main cupping method, supplemented with flash cupping and/or moving cupping.
First use empty cupping, which means the cups are removed after suction without delay, then practitioners should control the suction by gently moving the cup toward direction of DU and/or BL, repeat this moving for several times, finally cupping practitioners utilize the flaming heating power to achieve suction (minus pressure) inside the cups to make them apply on the desired part of the body.
Cups should retain for 10 minutes daily, patients accept the treatment three times weekly for totally 15 times.
|
|
Experimental: Cupping therapy (non-randomized)
Use retained cupping as the main cupping method, supplemented with flash cupping and/or moving cupping.
First use empty cupping, which means the cups are removed after suction without delay, then practitioners should control the suction by gently moving the cup toward direction of DU and/or BL, repeat this moving for several times, finally cupping practitioners utilize the flaming heating power to achieve suction (minus pressure) inside the cups to make them apply on the desired part of the body.
Cups should retain for 10 minutes daily, patients accept the treatment three times weekly for totally 15 times.
|
|
Active Comparator: Acupuncture (non-randomized)
Sterilize the selected points with alcohol, and then select the specific size of needles to do the acupuncture.
Do the manual stimulation for seconds after needles' insertion, including twist, pull up and deeper insert.
Needles should be withdrawn after 30 minutes.
Patients accept the treatment three times weekly for totally 15 times.
|
|
Active Comparator: Acupuncture (randomized)
Sterilize the selected points with alcohol, and then select the specific size of needles to do the acupuncture.
Do the manual stimulation for seconds after needles' insertion, including twist, pull up and deeper insert.
Needles should be withdrawn after 30 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients' compliance
Time Frame: Record the number of drop out or lost during the 5 weeks' treatment and 3 months' follow up duration (for an expected totally 17 weeks) and note the reason for missing data
|
Record the number of drop out or lost during the 5 weeks' treatment and 3 months' follow up duration (for an expected totally 17 weeks) and note the reason for missing data
|
|
Patients satisfactory for the treatment
Time Frame: The satisfactory for the treatment is investigated at week 5 (as the end of the treatment).
|
Satisfactory for the treatment is measured by a seven-score scale, with 1 for "very satisfied" and 7 for "very unsatisfied".
|
The satisfactory for the treatment is investigated at week 5 (as the end of the treatment).
|
Practitioners' attitude for the research model
Time Frame: Practitioners' attitude for the research model is investigated at week 5 (as the end of the treatment).
|
Individual interview or the focus group interview will be applied after the treatment, all the practitioners in the study (including acupuncturists and cupping therapy practitioners) will be interviewed to know their attitude for conducting the partially randomized patient preference trial model and their thoughts of this model compare to general randomized controlled trial.
|
Practitioners' attitude for the research model is investigated at week 5 (as the end of the treatment).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse events
Time Frame: Adverse events will be observed for the duration of 5 weeks' treatment and 3 months' follow-up, with an expected average of totally 17 weeks.
|
Researchers should note any minor or serious adverse event occurs during treatment and follow up duration, including cases and symptoms of patients with adverse events.
|
Adverse events will be observed for the duration of 5 weeks' treatment and 3 months' follow-up, with an expected average of totally 17 weeks.
|
Patients' expectation for the treatment
Time Frame: Patients' expectation is investigated at week 0
|
Patients' expectation is measured by a four-score scale, with 1 for "symptoms are totally disappear" and 4 for "no change for symptoms".
|
Patients' expectation is investigated at week 0
|
Visual Analogue Scale (VAS) for pain intensity
Time Frame: VAS should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively.
|
The length of scale of VAS is 100mm, 0 is representing for no pain, and 100 is representing unbearable pain which may affect appetite and quality of sleep.
Researchers should show the scale to patients, and note the scores of pain degree given by patients according to the scale.
|
VAS should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Widespread Pain Index (WPI)for pain intensity
Time Frame: WPI should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively.
|
WPI is defined according to the American College of Rheumatology diagnostic criteria (2002)for fibromyalgia.
|
WPI should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively.
|
Symptom Severity (SS) for pain intensity
Time Frame: SS should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively.
|
SS is defined according to the American College of Rheumatology diagnostic criteria (2002)for fibromyalgia
|
SS should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively.
|
Hamilton Depression Scale (HAMD)
Time Frame: HAMD is measured totally 3 times at week 0, week 5 and week 17, respectively.
|
HAMD is measured totally 3 times at week 0, week 5 and week 17, respectively.
|
|
Quality of life measured by The Medical Outcome Study 36-item short-form health survey (SF36)
Time Frame: SF36 is measured totally 3 times at week 0, week 5 and week 17, respectively.
|
SF36 is measured totally 3 times at week 0, week 5 and week 17, respectively.
|
|
Fibromyalgia Intensive Questionnaire (FIQ)
Time Frame: FIQ is measured totally 3 times at week 0, week 5 and week 17, respectively.
|
FIQ is measured totally 3 times at week 0, week 5 and week 17, respectively.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Huijuan Cao, Ph.D., Beijing University of Chinese Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cao H, Hu H, Colagiuri B, Liu J. Medicinal cupping therapy in 30 patients with fibromyalgia: a case series observation. Forsch Komplementmed. 2011;18(3):122-6. doi: 10.1159/000329329. Epub 2011 May 24.
- Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010 Apr;16(4):397-409. doi: 10.1089/acm.2009.0599.
- Cao HJ, Liu JP, Hu H, Wang NS. Using a partially randomized patient preference study design to evaluate the therapeutic effect of acupuncture and cupping therapy for fibromyalgia: study protocol for a partially randomized controlled trial. Trials. 2014 Jul 10;15:280. doi: 10.1186/1745-6215-15-280.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 23, 2013
Primary Completion (Actual)
September 15, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
May 22, 2013
First Submitted That Met QC Criteria
May 30, 2013
First Posted (Estimate)
June 5, 2013
Study Record Updates
Last Update Posted (Actual)
July 11, 2019
Last Update Submitted That Met QC Criteria
July 9, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0100604024
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Spaulding Rehabilitation HospitalNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of UtahTerminated
-
State University of New York - Upstate Medical...CompletedFibromyalgia, PrimaryUnited States
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
Clinical Trials on Acupuncture
-
Federal University of São PauloCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
Huazhong University of Science and TechnologyThe University of Hong Kong; Heilongjiang University of Chinese Medicine; Hubei...CompletedPolycystic Ovary SyndromeChina
-
China Medical University HospitalNot yet recruiting